Gontijo-de-Amorim et al 1 claim that fat enriched with the stromal vascular fraction (SVF) improves volume retention after facial lipotransfer. The authors describe a comparison of 5 patients injected with enriched fat vs 5 patients injected without SVF supplementation using computed tomography (CT). The authors report that the enriched fat group lost only 9.6% of its volume vs 24% in the untreated group. 1 The authors simply centrifuge the lipoaspirate rather than separating it enzymatically using collagenase to isolate adipose-derived stem cells. 1 Whether the cell pellet left at the bottom of the tube after centrifugation truly represents the SVF is open to question. 2 Although box plots are included, the actual measurement data for the 10 patients are not reported. The authors provide 2 clinical examples along with their axial CT scan images. The area of fat injection is indicated by 2 linear measurements. It is not clear how volumes were calculated from these linear dimensions. Regardless, errors in these measurements beg disclosure.
For the 26-year-old woman with mild Parry-Romberg syndrome injected with 65 mL of enriched fat, the linear measurement perpendicular to the 45-mm long axis is labeled "20 mm" on the preoperative image ( Figure  1A ). This length should be almost half the length of the 45-mm measurement. However, this length appears to be less than ¼ of the longer measurement. The Canfield 7.4.1 imaging software (Canfield Scientific, Fairfield, NJ) applies the measurement label directly onto the image, reducing the risk of error. Using this imaging software, the length of the shorter limb measures 1.06 cm (10.6 mm), not 20 mm, if the 45-mm measurement is used for calibration (note: the assumption is made that the longer measurement is the correct one). On the postoperative image ( Figure 1B ) this depth measurement is labeled 33 mm although the actual measurement is 1.31 cm (13.1 mm). Therefore, the postoperative increment in thickness is only 2.5 mm (1/10 inch), not 13 mm. The area increases from 4.37 cm 2 to 5.15 cm 2 , a difference of 0.78 cm 2 (18%). An area difference of 18% corresponds to a volume increment of 39% (1.18 × 1.18), assuming equal volume expansion in all 3 planes, or 0.61 cm 3 . Surprisingly, measurements on the contralateral untreated side reveal a decrease in area of 1.0 cm 2 (14%). The reason for this reduction in unclear. A possible explanation is weight loss during the 1-year period between CT studies. Controlling for this difference on the treated side raises the area increase on the treated right side slightly, to 0.90 cm 2 . These findings may be compared with the 18-yearold man with severe Parry-Romberg syndrome who was treated with a similar fat volume (70 mL) on the affected left side, but without SVF supplementation. In this patient, the labeled depth measurements are closer to the true measurements ( Figure 2 ). This patient's preoperative treatment area measures 4.58 cm 2 ( Figure 2A ) and the postoperative area is 6.78 cm 2 ( Figure 2B ), for a difference of 2.20 cm Despite similar fat injection volumes, the patient treated without the SVF supplement shows much more improvement in area and volume based on CT measurements. However, the volume increments for both patients are still far less than the total volume of fat injected. The patient with the advanced Parry-Romberg syndrome ( Figure 2 ) demonstrates a 7% (5 mL/70 mL) calculated volume retention at 12 months. The patient with mild hemifacial atrophy ( Figure 1 ) injected with enriched fat has even less fat retention (1 mL/65 mL), approximately, 1.5% of the original volume. Looking at it another way, the enriched-fat patient lost 98.5% of the injected volume, vs a 93% loss for the patient treated without fat enrichment. These findings stand in stark contrast to the authors' conclusions.
It is unclear why CT was used as opposed to magnetic resonance imaging (MRI), which avoids unnecessary patient radiation and provides excellent fat imaging 
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with T1-weighting. 3 It is more difficult to differentiate fat from other soft tissues on CT images. For this reason, MRI has been used in previous studies of facial fat volume. [3] [4] [5] Patients with Parry-Romberg syndrome or previous trauma may have confounding variables such as an unknown disease process causing fat absorption, or scarring that might limit soft tissue expansion. The results are unlikely to be generalizable to the cosmetic surgery population.
By injecting one side, the authors have a control side available, which is useful to control for known and unknown confounders such as weight gain. In the absence of contralateral measurements, patient weights would be useful to rule out weight gain as a confounder.
The authors state that their patients were randomized by order of enrollment.
1 This is not an acceptable form of randomization because it is subject to selection bias and inadequate concealment. 6, 7 The authors do not state how they randomly chose patients for CT studies. 1 The two featured patients differ greatly in the degree of hemifacial atrophy, favoring the enriched-fat patient. Selection bias likely affects the photographic evaluations.
Separating fat fractions, whether mechanically or enzymatically, adds time, cost, and resources to the treatment. This article does not provide the needed level of scientific rigor to justify adopting this method.
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